XERIS BIOPHARMA HOLDINGS INC (XERS)
US98422E1038 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -64.41M | -62.26M | -94.66M | -122.73M | -91.14M | |||
| Depreciation Amortization | 12.30M | 12.33M | 12.24M | 1.88M | 1.47M | |||
| Income Taxes - Deferred | N/A | -1.25M | -1.42M | N/A | N/A | |||
| Change In Working Capital | 1.93M | -6.29M | -35.15M | 11.85M | -2.80M | |||
| Interest Paid | 19.36M | 27.69M | 10.86M | 7.29M | 4.56M | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 9.93M | 10.45M | 16.10M | 13.46M | 11.91M | |||
| OPERATING CASH FLOW | -41.19M | -47.02M | -102.89M | -95.54M | -80.56M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.19M | -2.26M | -520.00K | -1.09M | -380.00K | |||
| Other Investing Activity | 20.51M | -3.74M | 34.99M | 99.05M | -27.03M | |||
| INVESTING CASH FLOW | 18.33M | -6.00M | 34.46M | 97.96M | -27.41M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 50.00M | 0.00 | 101.98M | 0.00 | 69.75M | |||
| Stock Issued/Repurchased | -2.54M | -428.00K | 30.37M | 27.30M | 66.63M | |||
| Other Financing Activity | -13.02M | -1.19M | -4.88M | -50.00K | -10.32M | |||
| FINANCING CASH FLOW | 34.44M | -1.61M | 127.47M | 27.25M | 126.06M | |||
| Exchange Rate Effect | N/A | 0.00 | 0.00 | 0.00 | -20.00K | |||
| CHANGE IN CASH | 11.58M | -54.64M | 59.04M | 29.67M | 18.07M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -41.19M | -47.02M | -102.89M | -95.54M | -80.56M | |||
| Capital Expenditure | -2.19M | -2.26M | -520.00K | -1.09M | -380.00K | |||
| FREE CASH FLOW | -43.37M | -49.29M | -103.41M | -96.63M | -80.94M | |||
All data in USD